Mechanistically, in DSS-induced colitis, Phd1 deficiency (i) diminishes apoptosis of enterocytes upon DSS treatment and, thus, increases the intestinal epithelial barrier function (EBF) (15) and (ii) skews macrophage polarization toward an M2 antiinflammatory phenotype (16). This evidence concerns the gene EGLN2 and colitis.